Europe Epilepsy Market and Competitive Landscape - 2017

  • ID: 4377610
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Epilepsy Market and Competitive Landscape - 2017, provides comprehensive insights into Epilepsy pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Epilepsy market size and drug sales. This research also provides insights into Epilepsy epidemiology and late stage pipeline.

The report is classified into nine sections - Epilepsy overview with definitions, symptoms, etiology, diagnosis, treatment options; Epilepsy pipeline insights covering late stage clinical trials pipeline; Epilepsy prevalence trends by countries; Epilepsy market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Epilepsy pipeline: Find out the drugs in clinical trials for Epilepsy by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Epilepsy epidemiology: Find out the prevalence of Epilepsy by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Epilepsy products: Identify key products marketed and prescribed for Epilepsy by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Epilepsy market size: Find out the market size for Epilepsy drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Epilepsy drug sales: Find out the sales of Epilepsy drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Epilepsy drugs sales forecast: Sales forecast for Epilepsy drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Epilepsy market share analysis: Find out the market shares of Epilepsy drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Epilepsy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Epilepsy market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Epilepsy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Epilepsy: Disease Overview
1.1. Epilepsy Symptoms
1.2. Epilepsy Etiology
1.3. Epilepsy Diagnosis
1.4. Epilepsy Treatment Options

2. Epilepsy Pipeline Insights
2.1. Epilepsy Phase 3 Clinical Trials
2.2. Epilepsy Phase 2 Clinical Trials
2.3. Epilepsy Phase 1 Clinical Trials

3. Epilepsy Epidemiology Analysis

4. Germany Epilepsy Market Insights
4.1. Marketed Products for Epilepsy in Germany
4.2. Germany Epilepsy Market Size & Forecast
4.3. Germany Epilepsy Product Sales Forecast
4.4. Germany Epilepsy Market Share Analysis

5. France Epilepsy Market Insights
5.1. Marketed Products for Epilepsy in France
5.2. France Epilepsy Market Size & Forecast
5.3. France Epilepsy Product Sales Forecast
5.4. France Epilepsy Market Share Analysis

6. Italy Epilepsy Market Insights
6.1. Marketed Products for Epilepsy in Italy
6.2. Italy Epilepsy Market Size & Forecast
6.3. Italy Epilepsy Product Sales Forecast
6.4. Italy Epilepsy Market Share Analysis

7. Spain Epilepsy Market Insights
7.1. Marketed Products for Epilepsy in Spain
7.2. Spain Epilepsy Market Size & Forecast
7.3. Spain Epilepsy Product Sales Forecast
7.4. Spain Epilepsy Market Share Analysis

8. UK Epilepsy Market Insights
8.1. Marketed Products for Epilepsy in UK
8.2. UK Epilepsy Market Size & Forecast
8.3. UK Epilepsy Product Sales Forecast
8.4. UK Epilepsy Market Share Analysis

9. Europe Epilepsy Market Insights
9.1. Europe Epilepsy Market Size & Forecast
9.2. Europe Epilepsy Product Sales Forecast
9.3. Europe Epilepsy Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Epilepsy Phase 3 Clinical Trials, Global, 2017
Table 2: Epilepsy Phase 2 Clinical Trials, Global, 2017
Table 3: Epilepsy Phase 1 Clinical Trials, Global, 2017
Table 4: Epilepsy Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Epilepsy in Germany, 2017
Table 6: Germany Epilepsy Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Epilepsy Product Sales ($mn), 2012 - 2021
Table 8: Germany Epilepsy Market Trends, 2012 - 2021
Table 9: Marketed Products for Epilepsy in France, 2017
Table 10: France Epilepsy Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Epilepsy Product Sales ($mn), 2012 - 2021
Table 12: France Epilepsy Market Trends, 2012 - 2021
Table 13: Marketed Products for Epilepsy in Italy, 2017
Table 14: Italy Epilepsy Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Epilepsy Product Sales ($mn), 2012 - 2021
Table 16: Italy Epilepsy Market Trends, 2012 - 2021
Table 17: Marketed Products for Epilepsy in Spain, 2017
Table 18: Spain Epilepsy Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Epilepsy Product Sales ($mn), 2012 - 2021
Table 20: Spain Epilepsy Market Trends, 2012 - 2021
Table 21: Marketed Products for Epilepsy in UK, 2017
Table 22: UK Epilepsy Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Epilepsy Product Sales ($mn), 2012 - 2021
Table 24: UK Epilepsy Market Trends, 2012 - 2021
Table 25: Europe Epilepsy Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Epilepsy Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Epilepsy Pipeline by Phase (%), Global, 2017
Figure 2: Epilepsy Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Epilepsy Market Size ($mn), 2012 - 2021
Figure 4: Germany Epilepsy Product Sales ($mn), 2012 - 2021
Figure 5: Germany Epilepsy Market Share by Products (%), 2016
Figure 6: Germany Epilepsy Market - Future Market Share (%), 2021
Figure 7: France Epilepsy Market Size ($mn), 2012 - 2021
Figure 8: France Epilepsy Product Sales ($mn), 2012 - 2021
Figure 9: France Epilepsy Market Share by Products (%), 2016
Figure 10: France Epilepsy Market - Future Market Share (%), 2021
Figure 11: Italy Epilepsy Market Size ($mn), 2012 - 2021
Figure 12: Italy Epilepsy Product Sales ($mn), 2012 - 2021
Figure 13: Italy Epilepsy Market Share by Products (%), 2016
Figure 14: Italy Epilepsy Market - Future Market Share (%), 2021
Figure 15: Spain Epilepsy Market Size ($mn), 2012 - 2021
Figure 16: Spain Epilepsy Product Sales ($mn), 2012 - 2021
Figure 17: Spain Epilepsy Market Share by Products (%), 2016
Figure 18: Spain Epilepsy Market - Future Market Share (%), 2021
Figure 19: UK Epilepsy Market Size ($mn), 2012 - 2021
Figure 20: UK Epilepsy Product Sales ($mn), 2012 - 2021
Figure 21: UK Epilepsy Market Share by Products (%), 2016
Figure 22: UK Epilepsy Market - Future Market Share (%), 2021
Figure 23: Europe Epilepsy Market Size ($mn), 2012 - 2021
Figure 24: Europe Epilepsy Product Sales ($mn), 2012 - 2021
Figure 25: Europe Epilepsy Market Share by Products (%), 2016
Figure 26: Europe Epilepsy Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll